Disrupting PQBP1–eEF2 protein-protein interaction: From synaptic translation to immunity and cancer
Neurochemistry International · 2026-06 · 196 · 106154
DOI: 10.1016/j.neuint.2026.106154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurochemistry International, 2026-06. Verfasst von Emadeldin M Kamel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef, 62514, Egypt. Electronic address: emad.abdelhameed@science.bsu.edu.eg. Hauptthemen laut MEDLINE: Neoplasms, Peptide Elongation Factor 2, Carrier Proteins, Synapses. Die Arbeit nennt 103 Literaturangaben. Gefördert von: Imam Mohammed Ibn Saud Islamic University, Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research.
Abstract (Originalsprache)
Polyglutamine-binding protein 1 (PQBP1) has emerged as a multifaceted regulator of gene expression, acting not only in the nucleus to influence transcription and splicing but also in the cytoplasm to control protein synthesis. A recent discovery identified a direct interaction between PQBP1 and the translation elongation factor eEF2, unveiling a new checkpoint in the elongation phase of protein synthesis. PQBP1 binds preferentially to the non-phosphorylated form of eEF2 and protects it from phosphorylation at Thr56 by its kinase eEF2K. Through this mechanism, PQBP1 promotes continuous elongation under conditions where unchecked eEF2K activity would otherwise stall ribosomes. The PQBP1-eEF2 complex plays critical roles in maintaining global proteome homeostasis and enabling activity-dependent protein synthesis in neurons. Disruption of this protein-protein interaction (PPI), whether by genetic mutations in PQBP1 or by sequestration of PQBP1 in cellular aggregates, has been linked to pathological states ranging from intellectual disability and impaired synaptic plasticity to altered innate immune responses and possibly tumorigenesis. In this review, we summarize the current understanding of the PQBP1-eEF2 interaction, its structural basis and regulation, the physiological processes it governs, and the consequences of its disruption in disease. We also discuss therapeutic considerations - when stabilizing this interaction might be beneficial (e.g. to restore synaptic function in neurodegeneration) versus when inhibiting it could be advantageous (e.g. to dampen excessive translation in cancer). Finally, we highlight experimental strategies and open questions for future research on this newly recognized nexus of translation control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef, 62514, Egypt. Electronic address: emad.abdelhameed@science.bsu.edu.eg.
- Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11623, Saudi Arabia.
- Physiology Division, Zoology Department, Faculty of Science, Beni-Suef University, P.O. Box 62521, Beni-Suef, Egypt.
- Department of Medical Biosciences, College of Veterinary Medicine, Qassim University, P.O. Box 6622, 51452, Buraydah, Saudi Arabia.
- Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, 51452, Saudi Arabia.
- Departamento de Química and Institute for Advanced research in chemical Science (IAdChem), Facultad de Ciencias, Módulo 13, Universidad Autónoma de Madrid, 28049, Madrid, Spain.
Förderung
- Imam Mohammed Ibn Saud Islamic University
- Imam Mohammed Ibn Saud Islamic University Deanship of Scientific Research
Zitieren
APA
Kamel, E. M., Khadrawy, S. M., Ali, M. A. M., Ahmed, N. A., Yassin, N. Y. S., Alkhedhairi, S., Alkhayl, F. F. A., & Lamsabhi, A. M. (2026). Disrupting PQBP1–eEF2 protein-protein interaction: From synaptic translation to immunity and cancer. Neurochemistry International, 196, 106154. https://doi.org/10.1016/j.neuint.2026.106154
Vancouver
Kamel EM, Khadrawy SM, Ali MAM, Ahmed NA, Yassin NYS, Alkhedhairi S, et al. Disrupting PQBP1–eEF2 protein-protein interaction: From synaptic translation to immunity and cancer. Neurochemistry International. 2026;196:106154. doi:10.1016/j.neuint.2026.106154
BibTeX
@article{Kamel2026,
author = {Kamel, Emadeldin M and Khadrawy, Sally Mostafa and Ali, Mohamed A M and Ahmed, Noha A and Yassin, Nour Y S and Alkhedhairi, Saleh and Alkhayl, Faris F Aba and Lamsabhi, Al Mokhtar},
title = {Disrupting PQBP1–eEF2 protein-protein interaction: From synaptic translation to immunity and cancer},
journal = {Neurochemistry International},
year = {2026},
volume = {196},
pages = {106154},
doi = {10.1016/j.neuint.2026.106154}
}
EUVIMED